2025-08-03 - Analysis Report
Okay, here's a comprehensive report analyzing Hims & Hers Health Inc (HIMS) based on the provided data.

**Report: Hims & Hers Health Inc (HIMS) Analysis**

**1. Relative Performance vs. S&P 500 (VOO)**

*   **Ticker:** HIMS
*   **Company Overview:** Hims & Hers Health Inc is a telehealth company providing access to personalized health and wellness solutions.
*   **HIMS Cumulative Return:** 243.55%
*   **VOO Cumulative Return:** 62.74%
*   **Absolute Divergence:** 198.5 (HIMS significantly outperforms VOO)
*   **Relative Divergence:** 76.7 (HIMS performance is in the 76.7th percentile of its historical divergence range compared to VOO.)
    *   This indicates that HIMS has significantly outperformed VOO historically, and its current outperformance is towards the higher end of its historical range.

**Alpha, Beta Analysis**

| Year        | CAGR   | MDD   | Alpha | Beta | Cap(B) |
| ----------- | ------ | ----- | ----- | ---- | ------ |
| 2019-2021   | -46.0% | 51.0% | -84.0% | -0.0 | 1.5    |
| 2020-2022   | -15.0% | 72.1% | -17.0% | -0.0 | 1.4    |
| 2021-2023   | -51.0% | 72.1% | -69.0% | -0.1 | 2.0    |
| 2022-2024   | 127.0% | 78.4% | 101.0% | -0.1 | 5.4    |
| 2023-2025   | 239.0% | 78.4% | 193.0% | -0.1 | 14.0   |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate demonstrates a significant turnaround from negative values in earlier periods to impressive growth in the most recent periods (2022-2024 and 2023-2025).
*   **MDD:** The Maximum Drawdown remains high across all periods, indicating substantial risk and volatility in the stock's performance.
*   **Alpha:** Alpha values are largely negative in earlier periods but turn highly positive in the recent periods, suggesting that the stock is generating significant excess returns compared to its benchmark.
*   **Beta:** The Beta values are consistently near zero or slightly negative, indicating a very low correlation with the market. This suggests that the stock's price movements are largely independent of overall market trends.
*   **Cap(B):** The market capitalization has grown substantially over time, particularly in the most recent periods, reflecting investor confidence and market valuation of the company.

**2. Recent Price Action**

*   **Current Price:** 62.55
*   **Previous Close:** 66.18
*   **Change:** -5.49 (Significant drop, indicating negative price action)
*   **5-Day Moving Average:** 62.64
*   **20-Day Moving Average:** 54.35
*   **60-Day Moving Average:** 54.47

**Analysis:**

*   The current price is below the 5-day moving average, suggesting potential short-term downward momentum.
*   The 5-day moving average is above the 20-day and 60-day moving averages, which suggests a recent upward trend prior to the most recent drop.
*   The significant price drop from the previous close (-5.49) indicates a notable negative event or market reaction affecting the stock.

**3. Technical Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.3358 (Low Risk)
*   **RSI:** 66.65 (Approaching overbought territory)
*   **PPO:** 2.60 (Positive, indicating an upward trend)
*   **Hybrid Signal:** "cash_0%_Buy 80% of cash (13 shares - Caution - MRI:0.34) Monthly invest 1.4% of total investment ($1,000.00)"
*   **Delta_Previous_Relative_Divergence:** 13.3 (+) (Short-term increase in relative outperformance vs. VOO)
*   **Expected Return:** -8.9% (Projected underperformance vs. S&P 500 with long-term investing)

**Analysis:**

*   The Market Risk Indicator (MRI) being in the "Low Risk" range is a positive sign.
*   The RSI value suggests the stock is approaching overbought territory, which may indicate a potential pullback.
*   The positive PPO confirms the recent upward trend.
*   The Hybrid Signal is recommending a cautious buying strategy with only 80% of available cash, based on the low MRI, suggesting a cautious approach is warranted.
*   The significant negative price change from the previous close reinforces the need for caution.
*   Despite the recent positive momentum, the negative expected return suggests that analysts anticipate long-term underperformance compared to the S&P 500. This is a crucial consideration for long-term investors.

**4. Recent News & Significant Events**

*   **2025-08-01:** Major business developments, regulatory changes, or market events.
*   **2025-07-30:** Analyst discussions on performance and outlook.
*   **2025-08-02:** Notable stock volatility.
*   **2025-07-31:** Market experts highlight both risks and opportunities.

**Analysis:**

*   The news snippets indicate recent volatility and potentially significant developments impacting the stock. Investors should investigate these events further to understand their implications. The analyst discussions and expert opinions are important for gauging market sentiment.

**5. Recent Earnings Analysis**

| 날짜       | EPS   | 매출      |
| ---------- | ----- | --------- |
| 2025-05-05 | 0.22  | 0.59 B$   |
| 2024-11-04 | 0.35  | 0.40 B$   |
| 2024-08-05 | 0.06  | 0.32 B$   |
| 2024-05-06 | 0.05  | 0.28 B$   |
| 2025-05-05 | 0.05  | 0.28 B$   |

**Analysis:**

*   The EPS (Earnings Per Share) is increasing, with a notable spike in the most recent quarter (2025-05-05).
*   The revenue is also steadily increasing, reflecting growth in the company's operations. The spike in revenue aligns with the EPS jump.
*   It's important to note there seems to be a duplicate entry for 2025-05-05 with different EPS and revenue figures. This discrepancy should be investigated to ensure data accuracy.

**6. Financial Information**

Revenue and Profitability:

| Quarter      | Revenue  | Profit Margin |
| ------------ | -------- | ------------- |
| 2025-03-31   | $0.59B   | 73.50%        |
| 2024-12-31   | $0.48B   | 76.81%        |
| 2024-09-30   | $0.40B   | 79.16%        |
| 2024-06-30   | $0.32B   | 81.30%        |
| 2024-03-31   | $0.28B   | 82.36%        |

Capital and Profitability:

| Quarter      | Equity   | ROE      |
| ------------ | -------- | -------- |
| 2025-03-31   | $0.55B   | 9.01%    |
| 2024-12-31   | $0.48B   | 5.46%    |
| 2024-09-30   | $0.44B   | 17.18%   |
| 2024-06-30   | $0.36B   | 3.67%    |
| 2024-03-31   | $0.34B   | 3.23%    |

**Analysis:**

*   **Revenue:** Revenue is steadily increasing, confirming the growth trend observed in the earnings analysis.
*   **Profit Margin:** Profit margin has decreased over the analyzed period, but it remains high. This may indicate increasing costs or changing pricing strategies.
*   **Equity:** Equity is increasing, suggesting the company is building value.
*   **ROE:** ROE (Return on Equity) is volatile, with a high value in Q3 2024.

**7. Summary and Overall Assessment**

Hims & Hers Health Inc. (HIMS) exhibits a mixed picture:

*   **Positive Momentum:** HIMS has significantly outperformed the S&P 500, with positive trends in revenue, EPS, and recent price action (prior to the most recent drop). The market capitalization has substantially increased.
*   **Short-Term Caution:** The recent significant price drop, RSI nearing overbought levels, and the cautious hybrid signal suggest potential short-term downside risk. The news snippets point to recent volatility and significant events.
*   **Long-Term Concerns:** The negative expected return indicates analysts anticipate long-term underperformance compared to the S&P 500, despite the recent strong growth. The decreasing profit margins is also a concern.
*   **Risk:** The high MDD indicates significant volatility and risk associated with the stock.

**Recommendation:**

Given the mixed signals, a cautious approach is recommended. Investors should:

*   **Investigate the cause of the recent price drop.** Understand the underlying factors driving the negative price action.
*   **Monitor the news and company announcements closely.** Stay informed about recent developments and their potential impact on the stock.
*   **Consider the long-term outlook.** Weigh the potential for long-term underperformance against the recent positive momentum.
*   **Manage Risk:** Due to the high volatility, consider managing risk through diversification, stop-loss orders, or smaller position sizes.
*   **Due to inconsistencies in EPS and Revenue reports, verify the accuracy of provided data.**

This analysis is based on the provided data and does not constitute financial advice. Consult with a qualified financial advisor before making any investment decisions.
